Home Healthcare Pharmaceuticals Brain Tumor Drugs Market

Brain Tumor Drugs Market Size, Share & Trends Analysis Report By Type (Glioblastoma, Meningioma, Pituitary Tumors, Ependymoma, Medulloblastoma, Others), By Therapy (Chemotherapy Drugs, Immunotherapy Drugs, Cell and Gene Therapy Drugs, Targeted Therapy Drugs, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: May 29, 2026 | Author: Dhanashri B | Format: | Report Code: SR7884DR | Pages: 220
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Brain Tumor Drugs Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Glioblastoma
    2. Meningioma
    3. Pituitary Tumors
    4. Ependymoma
    5. Medulloblastoma
    6. Others
  2. Brain Tumor Drugs Market, By Therapy 2022-2034 (USD MILLION/ Units)
    1. Chemotherapy Drugs
    2. Immunotherapy Drugs
    3. Cell and Gene Therapy Drugs
    4. Targeted Therapy Drugs
    5. Others
  3. Regional Brain Tumor Drugs Market
    1. North America
      1. North America Brain Tumor Drugs Market By Type 2022-2034 (USD MILLION/ Units)
        1. Glioblastoma
        2. Meningioma
        3. Pituitary Tumors
        4. Ependymoma
        5. Medulloblastoma
        6. Others
      2. North America Brain Tumor Drugs Market By Therapy 2022-2034 (USD MILLION/ Units)
        1. Chemotherapy Drugs
        2. Immunotherapy Drugs
        3. Cell and Gene Therapy Drugs
        4. Targeted Therapy Drugs
        5. Others
      3. U.S. Brain Tumor Drugs Market
        1. U.S. Brain Tumor Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Glioblastoma
          2. Meningioma
          3. Pituitary Tumors
          4. Ependymoma
          5. Medulloblastoma
          6. Others
        2. U.S. Brain Tumor Drugs Market By Therapy 2022-2034 (USD MILLION/ Units)
          1. Chemotherapy Drugs
          2. Immunotherapy Drugs
          3. Cell and Gene Therapy Drugs
          4. Targeted Therapy Drugs
          5. Others
      4. Canada Brain Tumor Drugs Market
        1. Canada Brain Tumor Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Glioblastoma
          2. Meningioma
          3. Pituitary Tumors
          4. Ependymoma
          5. Medulloblastoma
          6. Others
        2. Canada Brain Tumor Drugs Market By Therapy 2022-2034 (USD MILLION/ Units)
          1. Chemotherapy Drugs
          2. Immunotherapy Drugs
          3. Cell and Gene Therapy Drugs
          4. Targeted Therapy Drugs
          5. Others
    2. Europe
      1. Europe Brain Tumor Drugs Market By Type 2022-2034 (USD MILLION/ Units)
        1. Glioblastoma
        2. Meningioma
        3. Pituitary Tumors
        4. Ependymoma
        5. Medulloblastoma
        6. Others
      2. Europe Brain Tumor Drugs Market By Therapy 2022-2034 (USD MILLION/ Units)
        1. Chemotherapy Drugs
        2. Immunotherapy Drugs
        3. Cell and Gene Therapy Drugs
        4. Targeted Therapy Drugs
        5. Others
      3. U.K. Brain Tumor Drugs Market
        1. U.K. Brain Tumor Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Glioblastoma
          2. Meningioma
          3. Pituitary Tumors
          4. Ependymoma
          5. Medulloblastoma
          6. Others
        2. U.K. Brain Tumor Drugs Market By Therapy 2022-2034 (USD MILLION/ Units)
          1. Chemotherapy Drugs
          2. Immunotherapy Drugs
          3. Cell and Gene Therapy Drugs
          4. Targeted Therapy Drugs
          5. Others
      4. Germany Brain Tumor Drugs Market
        1. Germany Brain Tumor Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Glioblastoma
          2. Meningioma
          3. Pituitary Tumors
          4. Ependymoma
          5. Medulloblastoma
          6. Others
        2. Germany Brain Tumor Drugs Market By Therapy 2022-2034 (USD MILLION/ Units)
          1. Chemotherapy Drugs
          2. Immunotherapy Drugs
          3. Cell and Gene Therapy Drugs
          4. Targeted Therapy Drugs
          5. Others
      5. France Brain Tumor Drugs Market
        1. France Brain Tumor Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Glioblastoma
          2. Meningioma
          3. Pituitary Tumors
          4. Ependymoma
          5. Medulloblastoma
          6. Others
        2. France Brain Tumor Drugs Market By Therapy 2022-2034 (USD MILLION/ Units)
          1. Chemotherapy Drugs
          2. Immunotherapy Drugs
          3. Cell and Gene Therapy Drugs
          4. Targeted Therapy Drugs
          5. Others
      6. Spain Brain Tumor Drugs Market
        1. Spain Brain Tumor Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Glioblastoma
          2. Meningioma
          3. Pituitary Tumors
          4. Ependymoma
          5. Medulloblastoma
          6. Others
        2. Spain Brain Tumor Drugs Market By Therapy 2022-2034 (USD MILLION/ Units)
          1. Chemotherapy Drugs
          2. Immunotherapy Drugs
          3. Cell and Gene Therapy Drugs
          4. Targeted Therapy Drugs
          5. Others
      7. Italy Brain Tumor Drugs Market
        1. Italy Brain Tumor Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Glioblastoma
          2. Meningioma
          3. Pituitary Tumors
          4. Ependymoma
          5. Medulloblastoma
          6. Others
        2. Italy Brain Tumor Drugs Market By Therapy 2022-2034 (USD MILLION/ Units)
          1. Chemotherapy Drugs
          2. Immunotherapy Drugs
          3. Cell and Gene Therapy Drugs
          4. Targeted Therapy Drugs
          5. Others
      8. Russia Brain Tumor Drugs Market
        1. Russia Brain Tumor Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Glioblastoma
          2. Meningioma
          3. Pituitary Tumors
          4. Ependymoma
          5. Medulloblastoma
          6. Others
        2. Russia Brain Tumor Drugs Market By Therapy 2022-2034 (USD MILLION/ Units)
          1. Chemotherapy Drugs
          2. Immunotherapy Drugs
          3. Cell and Gene Therapy Drugs
          4. Targeted Therapy Drugs
          5. Others
      9. Nordic Brain Tumor Drugs Market
        1. Nordic Brain Tumor Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Glioblastoma
          2. Meningioma
          3. Pituitary Tumors
          4. Ependymoma
          5. Medulloblastoma
          6. Others
        2. Nordic Brain Tumor Drugs Market By Therapy 2022-2034 (USD MILLION/ Units)
          1. Chemotherapy Drugs
          2. Immunotherapy Drugs
          3. Cell and Gene Therapy Drugs
          4. Targeted Therapy Drugs
          5. Others
      10. Benelux Brain Tumor Drugs Market
        1. Benelux Brain Tumor Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Glioblastoma
          2. Meningioma
          3. Pituitary Tumors
          4. Ependymoma
          5. Medulloblastoma
          6. Others
        2. Benelux Brain Tumor Drugs Market By Therapy 2022-2034 (USD MILLION/ Units)
          1. Chemotherapy Drugs
          2. Immunotherapy Drugs
          3. Cell and Gene Therapy Drugs
          4. Targeted Therapy Drugs
          5. Others
      11. Rest of Europe Brain Tumor Drugs Market
        1. Rest of Europe Brain Tumor Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Glioblastoma
          2. Meningioma
          3. Pituitary Tumors
          4. Ependymoma
          5. Medulloblastoma
          6. Others
        2. Rest of Europe Brain Tumor Drugs Market By Therapy 2022-2034 (USD MILLION/ Units)
          1. Chemotherapy Drugs
          2. Immunotherapy Drugs
          3. Cell and Gene Therapy Drugs
          4. Targeted Therapy Drugs
          5. Others
    3. APAC
      1. APAC Brain Tumor Drugs Market By Type 2022-2034 (USD MILLION/ Units)
        1. Glioblastoma
        2. Meningioma
        3. Pituitary Tumors
        4. Ependymoma
        5. Medulloblastoma
        6. Others
      2. APAC Brain Tumor Drugs Market By Therapy 2022-2034 (USD MILLION/ Units)
        1. Chemotherapy Drugs
        2. Immunotherapy Drugs
        3. Cell and Gene Therapy Drugs
        4. Targeted Therapy Drugs
        5. Others
      3. China Brain Tumor Drugs Market
        1. China Brain Tumor Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Glioblastoma
          2. Meningioma
          3. Pituitary Tumors
          4. Ependymoma
          5. Medulloblastoma
          6. Others
        2. China Brain Tumor Drugs Market By Therapy 2022-2034 (USD MILLION/ Units)
          1. Chemotherapy Drugs
          2. Immunotherapy Drugs
          3. Cell and Gene Therapy Drugs
          4. Targeted Therapy Drugs
          5. Others
      4. Korea Brain Tumor Drugs Market
        1. Korea Brain Tumor Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Glioblastoma
          2. Meningioma
          3. Pituitary Tumors
          4. Ependymoma
          5. Medulloblastoma
          6. Others
        2. Korea Brain Tumor Drugs Market By Therapy 2022-2034 (USD MILLION/ Units)
          1. Chemotherapy Drugs
          2. Immunotherapy Drugs
          3. Cell and Gene Therapy Drugs
          4. Targeted Therapy Drugs
          5. Others
      5. Japan Brain Tumor Drugs Market
        1. Japan Brain Tumor Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Glioblastoma
          2. Meningioma
          3. Pituitary Tumors
          4. Ependymoma
          5. Medulloblastoma
          6. Others
        2. Japan Brain Tumor Drugs Market By Therapy 2022-2034 (USD MILLION/ Units)
          1. Chemotherapy Drugs
          2. Immunotherapy Drugs
          3. Cell and Gene Therapy Drugs
          4. Targeted Therapy Drugs
          5. Others
      6. India Brain Tumor Drugs Market
        1. India Brain Tumor Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Glioblastoma
          2. Meningioma
          3. Pituitary Tumors
          4. Ependymoma
          5. Medulloblastoma
          6. Others
        2. India Brain Tumor Drugs Market By Therapy 2022-2034 (USD MILLION/ Units)
          1. Chemotherapy Drugs
          2. Immunotherapy Drugs
          3. Cell and Gene Therapy Drugs
          4. Targeted Therapy Drugs
          5. Others
      7. Australia Brain Tumor Drugs Market
        1. Australia Brain Tumor Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Glioblastoma
          2. Meningioma
          3. Pituitary Tumors
          4. Ependymoma
          5. Medulloblastoma
          6. Others
        2. Australia Brain Tumor Drugs Market By Therapy 2022-2034 (USD MILLION/ Units)
          1. Chemotherapy Drugs
          2. Immunotherapy Drugs
          3. Cell and Gene Therapy Drugs
          4. Targeted Therapy Drugs
          5. Others
      8. Taiwan Brain Tumor Drugs Market
        1. Taiwan Brain Tumor Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Glioblastoma
          2. Meningioma
          3. Pituitary Tumors
          4. Ependymoma
          5. Medulloblastoma
          6. Others
        2. Taiwan Brain Tumor Drugs Market By Therapy 2022-2034 (USD MILLION/ Units)
          1. Chemotherapy Drugs
          2. Immunotherapy Drugs
          3. Cell and Gene Therapy Drugs
          4. Targeted Therapy Drugs
          5. Others
      9. South East Asia Brain Tumor Drugs Market
        1. South East Asia Brain Tumor Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Glioblastoma
          2. Meningioma
          3. Pituitary Tumors
          4. Ependymoma
          5. Medulloblastoma
          6. Others
        2. South East Asia Brain Tumor Drugs Market By Therapy 2022-2034 (USD MILLION/ Units)
          1. Chemotherapy Drugs
          2. Immunotherapy Drugs
          3. Cell and Gene Therapy Drugs
          4. Targeted Therapy Drugs
          5. Others
      10. Rest of Asia-Pacific Brain Tumor Drugs Market
        1. Rest of Asia-Pacific Brain Tumor Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Glioblastoma
          2. Meningioma
          3. Pituitary Tumors
          4. Ependymoma
          5. Medulloblastoma
          6. Others
        2. Rest of Asia-Pacific Brain Tumor Drugs Market By Therapy 2022-2034 (USD MILLION/ Units)
          1. Chemotherapy Drugs
          2. Immunotherapy Drugs
          3. Cell and Gene Therapy Drugs
          4. Targeted Therapy Drugs
          5. Others
    4. Middle East and Africa
      1. Middle East and Africa Brain Tumor Drugs Market By Type 2022-2034 (USD MILLION/ Units)
        1. Glioblastoma
        2. Meningioma
        3. Pituitary Tumors
        4. Ependymoma
        5. Medulloblastoma
        6. Others
      2. Middle East and Africa Brain Tumor Drugs Market By Therapy 2022-2034 (USD MILLION/ Units)
        1. Chemotherapy Drugs
        2. Immunotherapy Drugs
        3. Cell and Gene Therapy Drugs
        4. Targeted Therapy Drugs
        5. Others
      3. UAE Brain Tumor Drugs Market
        1. UAE Brain Tumor Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Glioblastoma
          2. Meningioma
          3. Pituitary Tumors
          4. Ependymoma
          5. Medulloblastoma
          6. Others
        2. UAE Brain Tumor Drugs Market By Therapy 2022-2034 (USD MILLION/ Units)
          1. Chemotherapy Drugs
          2. Immunotherapy Drugs
          3. Cell and Gene Therapy Drugs
          4. Targeted Therapy Drugs
          5. Others
      4. Turkey Brain Tumor Drugs Market
        1. Turkey Brain Tumor Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Glioblastoma
          2. Meningioma
          3. Pituitary Tumors
          4. Ependymoma
          5. Medulloblastoma
          6. Others
        2. Turkey Brain Tumor Drugs Market By Therapy 2022-2034 (USD MILLION/ Units)
          1. Chemotherapy Drugs
          2. Immunotherapy Drugs
          3. Cell and Gene Therapy Drugs
          4. Targeted Therapy Drugs
          5. Others
      5. Saudi Arabia Brain Tumor Drugs Market
        1. Saudi Arabia Brain Tumor Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Glioblastoma
          2. Meningioma
          3. Pituitary Tumors
          4. Ependymoma
          5. Medulloblastoma
          6. Others
        2. Saudi Arabia Brain Tumor Drugs Market By Therapy 2022-2034 (USD MILLION/ Units)
          1. Chemotherapy Drugs
          2. Immunotherapy Drugs
          3. Cell and Gene Therapy Drugs
          4. Targeted Therapy Drugs
          5. Others
      6. South Africa Brain Tumor Drugs Market
        1. South Africa Brain Tumor Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Glioblastoma
          2. Meningioma
          3. Pituitary Tumors
          4. Ependymoma
          5. Medulloblastoma
          6. Others
        2. South Africa Brain Tumor Drugs Market By Therapy 2022-2034 (USD MILLION/ Units)
          1. Chemotherapy Drugs
          2. Immunotherapy Drugs
          3. Cell and Gene Therapy Drugs
          4. Targeted Therapy Drugs
          5. Others
      7. Egypt Brain Tumor Drugs Market
        1. Egypt Brain Tumor Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Glioblastoma
          2. Meningioma
          3. Pituitary Tumors
          4. Ependymoma
          5. Medulloblastoma
          6. Others
        2. Egypt Brain Tumor Drugs Market By Therapy 2022-2034 (USD MILLION/ Units)
          1. Chemotherapy Drugs
          2. Immunotherapy Drugs
          3. Cell and Gene Therapy Drugs
          4. Targeted Therapy Drugs
          5. Others
      8. Nigeria Brain Tumor Drugs Market
        1. Nigeria Brain Tumor Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Glioblastoma
          2. Meningioma
          3. Pituitary Tumors
          4. Ependymoma
          5. Medulloblastoma
          6. Others
        2. Nigeria Brain Tumor Drugs Market By Therapy 2022-2034 (USD MILLION/ Units)
          1. Chemotherapy Drugs
          2. Immunotherapy Drugs
          3. Cell and Gene Therapy Drugs
          4. Targeted Therapy Drugs
          5. Others
      9. Rest of MEA Brain Tumor Drugs Market
        1. Rest of MEA Brain Tumor Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Glioblastoma
          2. Meningioma
          3. Pituitary Tumors
          4. Ependymoma
          5. Medulloblastoma
          6. Others
        2. Rest of MEA Brain Tumor Drugs Market By Therapy 2022-2034 (USD MILLION/ Units)
          1. Chemotherapy Drugs
          2. Immunotherapy Drugs
          3. Cell and Gene Therapy Drugs
          4. Targeted Therapy Drugs
          5. Others
    5. LATAM
      1. LATAM Brain Tumor Drugs Market By Type 2022-2034 (USD MILLION/ Units)
        1. Glioblastoma
        2. Meningioma
        3. Pituitary Tumors
        4. Ependymoma
        5. Medulloblastoma
        6. Others
      2. LATAM Brain Tumor Drugs Market By Therapy 2022-2034 (USD MILLION/ Units)
        1. Chemotherapy Drugs
        2. Immunotherapy Drugs
        3. Cell and Gene Therapy Drugs
        4. Targeted Therapy Drugs
        5. Others
      3. Brazil Brain Tumor Drugs Market
        1. Brazil Brain Tumor Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Glioblastoma
          2. Meningioma
          3. Pituitary Tumors
          4. Ependymoma
          5. Medulloblastoma
          6. Others
        2. Brazil Brain Tumor Drugs Market By Therapy 2022-2034 (USD MILLION/ Units)
          1. Chemotherapy Drugs
          2. Immunotherapy Drugs
          3. Cell and Gene Therapy Drugs
          4. Targeted Therapy Drugs
          5. Others
      4. Mexico Brain Tumor Drugs Market
        1. Mexico Brain Tumor Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Glioblastoma
          2. Meningioma
          3. Pituitary Tumors
          4. Ependymoma
          5. Medulloblastoma
          6. Others
        2. Mexico Brain Tumor Drugs Market By Therapy 2022-2034 (USD MILLION/ Units)
          1. Chemotherapy Drugs
          2. Immunotherapy Drugs
          3. Cell and Gene Therapy Drugs
          4. Targeted Therapy Drugs
          5. Others
      5. Argentina Brain Tumor Drugs Market
        1. Argentina Brain Tumor Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Glioblastoma
          2. Meningioma
          3. Pituitary Tumors
          4. Ependymoma
          5. Medulloblastoma
          6. Others
        2. Argentina Brain Tumor Drugs Market By Therapy 2022-2034 (USD MILLION/ Units)
          1. Chemotherapy Drugs
          2. Immunotherapy Drugs
          3. Cell and Gene Therapy Drugs
          4. Targeted Therapy Drugs
          5. Others
      6. Chile Brain Tumor Drugs Market
        1. Chile Brain Tumor Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Glioblastoma
          2. Meningioma
          3. Pituitary Tumors
          4. Ependymoma
          5. Medulloblastoma
          6. Others
        2. Chile Brain Tumor Drugs Market By Therapy 2022-2034 (USD MILLION/ Units)
          1. Chemotherapy Drugs
          2. Immunotherapy Drugs
          3. Cell and Gene Therapy Drugs
          4. Targeted Therapy Drugs
          5. Others
      7. Colombia Brain Tumor Drugs Market
        1. Colombia Brain Tumor Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Glioblastoma
          2. Meningioma
          3. Pituitary Tumors
          4. Ependymoma
          5. Medulloblastoma
          6. Others
        2. Colombia Brain Tumor Drugs Market By Therapy 2022-2034 (USD MILLION/ Units)
          1. Chemotherapy Drugs
          2. Immunotherapy Drugs
          3. Cell and Gene Therapy Drugs
          4. Targeted Therapy Drugs
          5. Others
      8. Rest of LATAM Brain Tumor Drugs Market
        1. Rest of LATAM Brain Tumor Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Glioblastoma
          2. Meningioma
          3. Pituitary Tumors
          4. Ependymoma
          5. Medulloblastoma
          6. Others
        2. Rest of LATAM Brain Tumor Drugs Market By Therapy 2022-2034 (USD MILLION/ Units)
          1. Chemotherapy Drugs
          2. Immunotherapy Drugs
          3. Cell and Gene Therapy Drugs
          4. Targeted Therapy Drugs
          5. Others
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.